Correspondence
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
N Engl J Med 2004; 350:943February 26, 2004
- Article
To the Editor:
I wish to point out that our report on early malignant progression of hereditary medullary thyroid cancer (Oct. 16 issue)1 contains a description of clinical material from 50 patients, of the 207 patients overall, that was also included in an article previously published in Surgery.2 Although asked to do so, we failed to inform the editors of each journal of the publication of these data in the other journal. We apologize for not having provided this information earlier.
2 ReferencesAndreas Machens, M.D.
Martin-Luther-Universität Halle-Wittenberg, D-06097 Halle (Saale), Germany
gensurg@medzin.uni-halle. de 1
Machens A ,Niccoli-Sire P ,Hoegel J , et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003;349:1517-1525
Full Text | Web of Science | Medline2
Machens A ,Holzhausen HJ ,Thanh PN ,Dralle H . Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 2003;134:425-431
CrossRef | Web of Science | Medline
- Citing Articles (4)
Citing Articles
1
Steven G. Waguespack, Thereasa A. Rich, Nancy D. Perrier, Camilo Jimenez, Gilbert J. Cote. (2011) Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nature Reviews Endocrinology 7:10, 596-607
CrossRef2
K Jamerson, MA Weber, GL Bakris, B Dahlöf, B Pitt, V Shi, A Hester, J Gupte, M Gatlin, EJ Velazquez. (2009) ACE-Hemmer-Fixkombinationen. Kalziumantagonist ist Diuretikum überlegen. focus neurogeriatrie 3:1-2, 21-22
CrossRef3
Anita K. Ying, Winston Huh, Sarah Bottomley, Douglas B. Evans, Steven G. Waguespack. (2009) Thyroid Cancer in Young Adults. Seminars in Oncology 36:3, 258-274
CrossRef4
Steven G. Waguespack. (2009) A Perspective from Pediatric Endocrinology on the Hereditary Medullary Thyroid Carcinoma Syndromes. Thyroid 19:6, 543-546
CrossRef
